1. Efavirenz: a review
2. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
3. Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor
4. bAndrews, C. W.; Chan, J. H.; Freeman, G. A.; Romines, K. R.; Tidwell, J. H.Benzophenones as inhibitors of reverse transcriptase. PCT Int. Appl. WO 2001017982A1, 2001.
5. Becker, S.; Lelezari, J.; Walworth, C.; Kumar, P.; Cade, J.; Ng-Cashin, J.; Kim, Y.; Scott, J.; St. Clair, M.; Jones, L.; Symonds, W.Antiviral Activity and Safety of GW695634, a Novel Next Generation NNRTI in NNRTI-resistant HIV-1 Infected Patients. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 2005, WePe6.2C03.